Clinical Trials Browser

Phase 2/3 × Niacinamide × Thoracic × Clear all

NCT02416739 2020-01-27

Anticancer Activity of Nicotinamide on Lung Cancer

Phase 2/3 Unknown

Carcinoma, Non-Small-Cell Lung